Victory and defeat at Heraclea - Treating hepatitis C infection following liver transplantation with telaprevir and boceprevir

Journal of Hepatology

Volumn 60, Issue 1, 2014, Pages 6-8

  Charlton, Michael ^a   Dick, Travis ^a  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; AZATHIOPRINE; BOCEPREVIR; CALCINEURIN INHIBITOR; CYCLOSPORIN; CYTOCHROME P450; DIGOXIN; EVEROLIMUS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LOPINAVIR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHADONE; MIDAZOLAM; MORPHINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON; PREDNISONE; PYRROLE; RAPAMYCIN; RIBAVIRIN; RITONAVIR; TACROLIMUS; TELAPREVIR;

ALLOGRAFT; ANEMIA; ANTIVIRAL THERAPY; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CAUSE OF DEATH; CHOLESTATIC HEPATITIS; DRUG HALF LIFE; DRUG WITHDRAWAL; GASTROINTESTINAL TRACT; GRAFT FAILURE; GRAFT SURVIVAL; HEMATOCRIT; HEPATITIS C; HUMAN; INTESTINE ABSORPTION; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER DISEASE; LIVER TRANSPLANTATION; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; UNSPECIFIED SIDE EFFECT; DISEASE ASSOCIATION; EDITORIAL; LIVER CIRRHOSIS; TREATMENT RESPONSE;

FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER TRANSPLANTATION; MALE; PROTEASE INHIBITORS;

EID: 84890560259     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.10.006     Document Type: Editorial

References (11)

1. M. Charlton, and E. Seaberg Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Liver Transpl Surg 5 1999 107 114
2. J. Fudin, D.V. Fontenelle, H.R. Fudin, C. Carlyn, D.A. Hinden, and C.C. Ashley Potential p-glycoprotein pharmacokinetic interaction of telaprevir with morphine or methadone J Pain Palliat Care Pharmacother 27 2013 261 267
3. V. Garg, G. Chandorkar, H.F. Farmer, F. Smith, K. Alves, and R.P. van Heeswijk Effect of telaprevir on the pharmacokinetics of midazolam and digoxin J Clin Pharmacol 52 2012 1566 1573
4. Y.H. Oo, T. Dudley, P. Nightingale, G. Haydon, and D. Mutimer Tacrolimus and cyclosporine doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation Liver Transpl 14 2008 81 87
5. M. Kugelmas, M.J. Osgood, J.F. Trotter, T. Bak, M. Wachs, and L. Forman Hepatitis c virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection Liver Transpl 9 2003 1159 1165
6. A.B. Jain, R. Venkataramanan, B. Eghtesad, A. Marcos, M. Ragni, and R. Shapiro Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients Liver Transpl 9 2003 954 960
7. Garg V., R. van Heeswijk, J.E. Lee, K. Alves, P. Nadkarni, and X. Luo Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus Hepatology 54 2011 20 27
8. E. Hulskotte, S. Gupta, F. Xuan, M. van Zutven, E. O'Mara, and H.P. Feng Pharmacokinetic interaction between the hepatitis c virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers Hepatology 56 2012 1622 1630
9. A. Coilly, V. Furlan, B. Roche, C. Barau, C. Noel, and L. Bonhomme-Faivre Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis c recurrence Antimicrob Agents Chemother 56 2012 5728 5734
10. J. O'Leary, G.J. McKenna, G.B. Klintmalm, and G.L. Davis Effect of telaprevir on the pharmacokinetics of sirolimus in liver transplant recipients Liver Transpl 19 2013 463 465
11. F. Akhlaghi, and A.K. Trull Distribution of cyclosporin in organ transplant recipients Clin Pharmacokinet 41 9 2002 615 637